Christine Rothe | Chief Development Officer
iOmx Therapeutics AG

Christine Rothe serves as Chief Development Officer at iOmx Therapeutics where she is responsible for research and development programs. Christine has a long-standing track record in discovery and development of drug candidates. Before joining iOmx, Christine held positions of increasing responsibility in R&D and Alliance Management at Pieris Pharmaceuticals and MorphoSys AG. At Pieris, Christine played a major role in shaping the drug discovery process and bringing bispecifics in immuno-oncology from the start of the program into the clinic. Christine started her industry career at MorphoSys leading technology development as well as therapeutic antibody projects.